Open question: how should we measure long-term adherence to GLP-1 therapy?
Trials run for a few years, but patients may take these drugs for decades. What outcome measures would actually tell us about long-term adherence?
No source linked
Rigor
Unreviewed · no source
No source is linked. Treat this as opinion or an open question. Reach (likes, shares) never changes this label.